Mullen Group Ltd. Retains Controversial Board Member Sonia Tibbatts in Pivotal Move for Corporate Diversity”
In an unanticipated and potentially transformative governance move, the Board of Directors of Mullen Group Ltd., a preeminent player in…
In an unanticipated and potentially transformative governance move, the Board of Directors of Mullen Group Ltd., a preeminent player in…
Nominee
In a significant move within the biopharmaceutical industry, Comanche Biopharma, a clinical-stage company spearheading innovative therapy for preeclampsia, has announced…